Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350

Q1 FY27 results · Apr–Jun 2026

Dr. Agarwal's Health Care reported revenue from operations of ₹614.02 crore (up 26.0% from Q1 FY26) and net profit of ₹55.02 crore (up 44.6% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations614.02487.42+26.0%564.11+8.8%
Other income6.4113.39−52.1%12.58−49.0%
Total income620.43500.81+23.9%576.69+7.6%
Profit before tax75.1453.60+40.2%76.62−1.9%
Net profit for the period55.0238.06+44.6%49.96+10.1%
Attributable to shareholders of the company45.2330.05+50.5%39.71+13.9%
EPS, basic (₹)1.430.95+50.5%1.25+14.4%
Net margin (%)9.07.88.9
Standalone · ₹ crore
ItemQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue from operations382.62301.72+26.8%347.86+10.0%
Other income3.4213.03−73.8%6.21−44.9%
Total income386.04314.75+22.6%354.07+9.0%
Profit before tax22.5015.59+44.3%18.41+22.2%
Net profit for the period16.6710.11+64.9%10.60+57.3%
EPS, basic (₹)0.530.32+65.6%0.33+60.6%
Net margin (%)4.43.43.0
Consolidated
Filed with BSE
04 Aug 2026, 17:19 IST
Board meeting
04 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
04 Aug 2026, 17:19 IST
Board meeting
04 Aug 2026
Period
01 Apr 2026 to 30 Jun 2026
Review status
Unaudited
Source
XBRL filing on BSE